$RGBP Regen BioPharma, Inc. Licenses NR2F6 Technology for

New Post Public Reply Private Reply Replies (0) Message Board

budfoxfun

Mar 2, 2017 at 2:46 PM 152

$RGBP Regen BioPharma, Inc. Licenses NR2F6 Technology for Cancer Treatment and Autoimmune Disorders to CheckPoint Immunology Inc.
http://finance.yahoo.com/news/regen-biopharma...00603.html

Newer

Older